Skip to content

Autosomal Recessive Optic Atrophy Opa7 Type C2751812

Published: July 22, 2026Updated: August 25, 2026

An inherited optic nerve disorder causing progressive vision loss, typically beginning in childhood or early adulthood. It affects the optic nerve's ability to transmit visual signals. Low-vision aids and monitoring for complications help manage this condition.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden visual deterioration

!

Progressive vision loss

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Color vision deficiency

(ophthalmologic)

Optic disc pallor

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular ophthalmologic examinations

Comprehensive eye examinations including visual acuity testing, visual field assessment, and retinal imaging to monitor disease progression and detect complications.

monitoring
3

Low vision rehabilitation

Provision of low vision aids including magnifiers, specialized lighting, and adaptive technologies to maximize functional vision and maintain independence in daily activities.

lifestyle

Additional treatment options

Genetic counseling

Professional genetic counseling for patients and families to understand inheritance patterns, recurrence risks, and available family planning options.

psychological

Occupational therapy

Training in adaptive techniques and environmental modifications to compensate for vision loss in work, self-care, and daily activities.

lifestyle

Neuroprotective supplement considerations

Some clinicians recommend supplements containing antioxidants such as vitamin E, coenzyme Q10, or alpha-lipoic acid, though evidence for efficacy in OPA7 is limited.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Recessive Optic Atrophy Opa7 Type C2751812?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kerrison JB, Biousse V. Inherited optic neuropathies: update on genetic mechanisms and clinical features. Curr Opin Ophthalmol. 2020.

review2020
2

American Academy of Ophthalmology. Preferred Practice Pattern: Hereditary Retinal and Optic Nerve Disorders. Ophthalmology. 2022.

guideline2022
3

Yu-Wai-Man P, Chinnery PF. Clinical and Molecular Characterization of Autosomal Recessive Optic Atrophy Associated with TMEM126A Mutations. Invest Ophthalmol Vis Sci. 2019.

clinical_trial2019
4

Carelli V, La Morgia C, Valentino ML. Mitochondrial optic neuropathies: a meta-analysis of genotype-phenotype correlations. JAMA Ophthalmol. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Autosomal Recessive Optic Atrophy Opa7 Type C2751812. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy